Argenica Therapeutics Welcomes New Director

Argenica Therapeutics Ltd (AU:AGN) has released an update.

Argenica Therapeutics Limited has announced the appointment of Robert Black as a new director on September 17, 2024. Black has a notable interest in the company, with an indirect holding of 25,000 ordinary shares through Black Magic Enterprises Pty Ltd and the RH Black Super Fund, where he serves as director, shareholder, trustee, and beneficiary. There are no direct holdings or interests in contracts reported for Black at this time.

For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.